The QualityStocks Daily Thursday, November 29th, 2018

Today's Top 3 StockMarketWatch

QualityStocks (BTHE) +131.58%

The Street (TNXP) +83.42%

StocksToBuyNow (TVTV) +80.18%

The QualityStocks Daily Stock List

Boston Therapeutics, Inc. (BTHE)

MissionIR, Tiny Gems, SmallCapVoice, PennyStocks24, FeedBlitz, Wall Street Mover, RedChip, TaglichBrothers, Stock News Now, TopPennyStockMovers, and Information Solutions Group reported earlier on Boston Therapeutics, Inc. (BTHE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline centers on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. OTCQB-listed, Boston Therapeutics is based in Lawrence, Massachusetts.

The Company’s product pipeline includes BTI-320. This is a non-systemic, non-toxic, chewable complex carbohydrate-based compound. The design of it is to lessen post-meal glucose elevation. BTI-320 is a proprietary polysaccharide.

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, reducing the availability of glucose for absorption into the bloodstream.

Boston Therapeutics entered a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. In addition, the Company’s product pipeline includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it at first is to treat lower limb ischemia associated with diabetes.

Boston Therapeutics’ product pipeline also includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is the Company’s veterinary facsimile to IPOXYN™.

Furthermore, Boston Therapeutics developed and markets SUGARDOWN®. This is a non-systemic, complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose.

SUGARDOWN®, in its present formulation, is a natural sugar blocker dietary supplement product made completely from a non-digestible sugar molecule, which can help people maintain healthier weight levels. It is the first chewable tablet of its kind.

In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical Company Limited (APC), began the SUGARDOWN® clinical trial in Hong Kong. Advance is evaluating the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong (CUHK), Prince of Wales Hospital.

In April 2017, Boston Therapeutics and Advance Pharmaceutical announced the fully funded new trial plans to support the safety and efficacy of BTI-320, starting with a randomized, placebo-controlled, double-blinded, multi-center, global study on type 2 diabetic (T2D) patients.

Last month, Boston Therapeutics announced that effective sugar reduction with the investigative BTI-320 formulation necessitates only one tablet. Findings were confirmed by the most recent proof-of-concept study conducted in high-risk Chinese subjects with pre-diabetes. A formulation, in the form of a dietary supplement, is currently available as SUGARDOWN®, SUGARBLOCK and SUGARBALANCE in the Unites States and Asia.

Moreover, in December, Boston Therapeutics announced that it expanded its partnership with Advance Pharmaceutical Company Limited (APC) to distribute in Korea. Following the extension of the licensing and distribution agreement with APC, a registered formulation, marketed as a food supplement under the name SUGARBALANCE is now available in Korea.  This significant shipment marks a start to the sales of SUGARBALANCE in the territory.

Boston Therapeutics, Inc. (BTHE), closed Thursday's trading session at $0.044, up 131.58%, on 122,100 volume with 8 trades. The average volume for the last 3 months is 28,841 and the stock's 52-week low/high is $0.013/$0.116.

chart

CareView Communications, Inc. (CRVW)

Tiny Gems, MissionIR, Stockopedia, Stock Invest, Monster Stocks Pick, FeedBlitz, Real Pennies, PennyTrader Publisher, Wall Street Resources, Wallet Investor, Plunkett Research, TradingView, BabyBulls, Pink Investing, Stock Stars, and Capital Cube reported previously on CareView Communications, Inc. (CRVW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CareView Communications, Inc. is an Information Technology (IT) provider to the healthcare industry. CareView provides the next generation of patient care through its cutting-edge data and patient monitoring system. This system connects patients, families and healthcare professionals (the CareView System®). The CareView System can help a hospital reduce sitter costs, patient falls and injuries, manage patient flow, improve internal communications, and consolidate vendors. OTCQB-listed, CareView Communications has its corporate headquarters in Lewisville, Texas.

The CareView System is HIPAA (Health Insurance Portability and Accountability Act) -compliant and secure. The System does not record anything. Additionally, it can include consent processes and privacy options. Pertaining to hospital benefits, the CareView System enables patients to watch first-run movies and access high-speed internet. The result of this is increased patient satisfaction.

CareView Communications’ proprietary, high-speed data network system may be installed throughout a healthcare facility to provide the facility with recurring revenue and infrastructure for future applications. The CareView System allows for close observation of high-risk patients from numerous locations. The CareView Connect® mobile application provides patient monitoring and critical communication tools from an existing Wi-Fi Android or iOS device. The CareView System employs an infrared camera in patient rooms to deliver real-time visual monitoring 24/7.

CareView Communications offers its CareView Connect Senior Care Quality of Life System™. This is a unique family of products and services, which improve the quality of life and safety of seniors who reside in independent and assisted living facilities, or who live alone at home. The CareView Connect Senior Care Quality of Life System™ consists of a small emergency assist button or pendant, passive motion sensors, bed sensors, and event sensors. The CareView Connect System passively monitors a resident's daily activities.

Last month, CareView Communications announced the execution of a three-year group purchasing agreement with Pandion Optimization Alliance. Pandion is a 70-year old not-for-profit group purchasing organization dedicated to member hospitals, non-acute health-care related facilities and related industries. Pandion GPO has thousands of members covering 50 states. Pandion GPO provides an assortment of supply chain services and solutions including group purchasing and supply chain consulting to help lessen costs, streamline operations and improve performance of its members.

CareView Communications, Inc. (CRVW), closed Thursday's trading session at $0.0225, down 8.91%, on 4,280 volume with 2 trades. The average volume for the last 3 months is 114,989 and the stock's 52-week low/high is $0.012/$0.10.

chart

AEON Global Health Corp. (AGHC)

Amigo Bulls, Stock Target Advisor, Stockopedia, Investors Hangout, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockflare, and Dividend Investor reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company provides diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. AEON formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. OTCQB-listed, AEON Global Health has its corporate office in Gainesville, Georgia.

The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results. AEON’s chief business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.

AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. It provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses. These include CHF, COPD and Diabetes.

Concerning Toxicology Testing, AEON Global Health provides accurate and fast quantitative testing of drug metabolite levels in urine and oral fluids. The Company’s testing covers more than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.

AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.

In May 2018, AEON Global Health announced it earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization’s commitment to providing safe and effective patient care.

AEON Global Health underwent a thorough onsite survey earlier in 2018. During the review, a Joint Commission expert surveyor evaluated compliance with laboratory standards related to a number of areas. This included document and process control, healthcare-associated conditions, risk reduction, as well as staff qualifications and competency. Additionally, the surveyor conducted onsite observations and interviews.

AEON Global Health Corp. (AGHC), closed Thursday's trading session at $0.68, up 8.16%, on 2,205 volume with 2 trades. The average volume for the last 3 months is 4,513 and the stock's 52-week low/high is $0.43/$1.25.

chart

Nemaska Lithium, Inc. (NMKEF)

Investing News, Street Insider, Metals News, Mining and Energy, Insider Financial, Stockhouse, Capital Equity Review, InvestorsHub, YCharts, Junior Mining Network, Streetwise Reports, Uptick News Wire, InvestorIntel, OTC Markets, and Private Capital Journal reported earlier on Nemaska Lithium, Inc. (NMKEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A developing chemical company, Nemaska Lithium, Inc.’s activities will be vertically integrated, from spodumene mining to the commercialization of high-purity lithium hydroxide and lithium carbonate. These lithium salts are primarily for the lithium-ion battery market. Nemaska Lithium will be operating the Whabouchi mine in the Province of Quebec. The Whabouchi mine is one of the richest lithium spodumene deposits in the world - in volume and grade. Nemaska Lithium is headquartered in Quebec City, Quebec. The Company’s shares trade on the OTC Markets’ OTCQX.

The spodumene concentrate produced at the Whabouchi mine will undergo processing at the Shawinigan plant utilizing a unique membrane electrolysis process for which Nemaska Lithium holds a number of patents. The Company has received a notice of allowance of a main patent application on its proprietary process to produce lithium hydroxide and lithium carbonate. It is pursuing patent protection on this process in manifold international jurisdictions.

The Whabouchi Property consists of one block totaling 33 claims encompassing an area of 1,761.9 ha. The Company 100 percent owns the claims. The Feasibility Study (FS) outlines a combined open pit and underground mine. Nemaska Lithium states that the Nemaska Whabouchi spodumene deposit in the Eeyou Istchee/James Bay Region of Quebec, near the Cree community of Nemaska, should have an initial lithium mine life of 26 years.

In May 2018, Nemaska Lithium announced the signing of a supply agreement of spodumene concentrate with Hanwa Co., Ltd. acting as agent for General Lithium Corp. (GLC), GLC having signed the Agreement as intervenor. With the Agreement and via its wholly-owned subsidiary Nemaska Lithium Whabouchi Mine, Inc., Nemaska Lithium will supply a significant quantity of spodumene concentrate on a take-or-pay basis at a market priced-based formula, at the time of delivery. The supply period will begin subsequent to the construction of the Whabouchi Mine. It will continue up to the full ramp-up of the electrochemical plant in Shawinigan.

Last week, Nemaska Lithium provided a construction project and development update for its Whabouchi mine and electrochemical plant in Shawinigan. Presently, Project construction at both sites is on track. Concentrate production is anticipated to commence in H2 2019 with lithium salts production expected in H2 2020. Moreover, $315.9M or 36 percent of the total project budget has been committed; $177.3M at the Whabouchi mine, and $138.6M at the Shawinigan electrochemical plant.

Nemaska Lithium, Inc. (NMKEF), closed Thursday's trading session at $0.60475, up 0.79%, on 411,550 volume with 52 trades. The average volume for the last 3 months is 198,404 and the stock's 52-week low/high is $0.46/$1.96.

chart

THC BioMed Intl. Ltd. (THCBF)

Stockhouse, Tip Ranks, Markets and Markets, Marketbeat, Insider Financial, Morningstar, InvestorsHub, YCharts, Market Screener, Marketwired, Investors Hangout, Barchart, MarketWatch, Wallet Investor, GuruFocus, and TradingView reported previously on THC BioMed Intl. Ltd. (THCBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

THC BioMed Intl. Ltd. is an ACMPR (Access to Cannabis for Medical Purposes Regulations) Licensed Producer and Canada's largest supplier of legal Cannabis Genetics. Additionally, the Company produces and sells dried and fresh marijuana and cannabis oil for medical purposes. At present, THC offers more than two dozen different genetic strains for sale. The Company has the largest variety of genetic strains available in Canada for home growers. OTCQB-listed, THC BioMed is headquartered in Kelowna, British Columbia.

THC BioMed has its Clone Shipper acquisition. It is laying the groundwork in preparation for becoming the wholesaler of choice of live clones to the expected home growers' market. The patented design of the Clone Shipper 3.0 containers allows for an LED light to keep the clone in the growing vegetative stage for 12 to 24 hours during shipment. THC is utilizing the newly designed Clone Shipper 3.0 containers to ship live cannabis plants throughout Canada.

The Company has created THC2GO Dispensaries. THC, via its wholly-owned subsidiary "THC2GO Dispensaries", started the application process to become a cannabis retailer in the Province of Manitoba. In addition, THC2GO Dispensaries’ intention is to apply for retail outlets in each Canadian province that allows private cannabis retail outlets.

THC BioMed has developed a cannabis beverage. This beverage imitates alcohol in that the uplifting and energizing effects of the cannabis is felt by the consumer in a short period of time. The Company believes that this beverage is a solution to a major problem with cannabis beverages and edibles, as current products cause fatigue and drowsiness. Production and sale of the beverage is not presently legal in Canada, it may become legal at a later date. THC BioMed intends to patent the formula.

This month, THC BioMed Intl announced that it received a Cannabis Act and Cannabis Regulations License from Health Canada on November 8, 2018. This is the new license under the Cannabis Act. It permits the Company to grow, produce and sell cannabis products on a large scale under the new regime.

Moreover, THC BioMed Intl announced that Clone Shipper, its wholly-owned subsidiary, received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) concerning the Company's patent application for the invention of an illuminated shipping container for live cannabis plants. THC now has three months to conduct a final review of its patent application, file any required amendments, submit the formal drawings and pay the Issue fee. The Notice of Allowance is not a grant of patent rights; it is a notice from the Examiner that the Application is being allowed. 

THC BioMed Intl. Ltd. (THCBF), closed Thursday's trading session at $0.34471, up 1.39%, on 5,364 volume with 22 trades. The average volume for the last 3 months is 101,223 and the stock's 52-week low/high is $0.3097/$2.65.

chart

Bimini Capital Management, Inc. (BMNM)

Zacks, Capital Cube, Tip Ranks, Wallmine, Stockopedia, Information Vine, OTC Markets, InvestorsHub, MarketWatch, Stockhouse, Trading View and Pink Investing reported previously on Bimini Capital Management, Inc. (BMNM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Bimini Capital Management, Inc. primarily invests in mortgage-backed securities (MBS) in the United States. The Company is an asset manager. It invests mainly in residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac), and the Government National Mortgage Association (Ginnie Mae). A specialty finance company, Bimini Capital Management is based in Vero Beach, Florida. Established in 2003, the Company lists on the OTC Markets Group’s OTCQB.

Bimini Capital Management’s objective is to earn returns on the spread between the yield on its assets and its costs. This includes the interest expense on the funds it borrows. Additionally, the Company generates a substantial portion of its revenue serving as the manager of the MBS portfolio of Orchid Island Capital, Inc.  Orchid Island Capital is a publicly-traded real estate investment trust (REIT) (NYSE: ORC).

As manager, Bimini Capital Management is responsible for administering Orchid Island Capital’s business activities and daily operations.  With this management agreement, Bimini Advisors provides Orchid with its management team. This includes its officers, along with suitable support personnel. Furthermore, Bimini maintains a common stock investment in Orchid.

Bimini Capital Management also manages the portfolio of its wholly-owned subsidiary, Royal Palm Capital, LLC. Royal Palm Capital is managed with an investment strategy similar to that of Orchid Island Capital.

At the beginning of November, Bimini Capital Management announced results of operations for the three month period ended September 30, 2018. Q3 2018 highlights include Net Income of $0.9 million, or $0.07 per common share. Book Value per Share was $4.22.

The results for Q3 included Advisory Services Revenue of $1.9 million, Interest and Dividend Income of $2.4 million, Interest Expense of $1.4 million, Net Realized and Unrealized Losses of $0.2 million, Operating Expenses of $1.5 million and an Income Tax Provision of $0.3 million.

Bimini Capital Management, Inc. (BMNM), closed Thursday's trading session at $2.10, even for the day, on 2,000 volume with 1 trade. The average volume for the last 3 months is 1,898 and the stock's 52-week low/high is $1.86/$2.75.

chart

CleanSpark, Inc. (CLSK)

WalletInvestor, OTC Markets, InvestorsHub, Stockhouse, The Street, Market Exclusive, 4-Traders, Investor Place, Penny Stock Tweets, Investors Hangout, StreetInsider, and Stock News Now reported on CleanSpark, Inc. (CLSK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for innovative distributed energy resource management systems. The Company provides advanced energy software and control technology, which enables a plug-and-play enterprise solution to modern energy challenges. Incorporated in 1987, the Company previously went by the name Stratean Inc. It changed its corporate name to CleanSpark, Inc. in November of 2016.

The Company’s products include DNAPOWERPLAN™, Turnkey Microgrid Development Services, and mPULSE GRID MANAGEMENT™. CleanSpark’s PowerPlan shows owners, tenants and stakeholders how to use energy generation, storage and advanced automation to attain 25, 50 or even 100 percent grid independence.

Regarding Turnkey Microgrid Development Services, CleanSpark develops, constructs, installs and maintains income producing nano and microgrids. CleanSpark helps customers make money through developing their own energy assets. The Company has grids that have been in continuous operation since 2014.

Pertaining to mPULSE GRID MANAGEMENT™, the Company’s mPulse software and controls package collects, archives, and also analyzes data 24/7. This provides real-time control and reporting and ensures that a customer’s projects are performing according to the DNA PowerPlan. Via advanced monitoring, predictive analytics and professional maintenance, CleanSpark ensures optimal performance of a customer’s microgrid and maximum revenue.

CleanSpark’s services comprise intelligent solar monitoring solutions, microgrid design and engineering, project development consulting services, system installation and consulting, and turn-key microgrid implementation services. Additionally, the Company combines its microgrid services with a pioneering and patented stratified downdraft gasifier.

Through integrating new and existing energy generation and storage assets with advanced load management capacities, the Company’s software allows energy generated locally to be shared with other interconnected microgrids.

In January 2018, CleanSpark announced it was officially contracted to design a turn-key, fully engineered 'off-grid' solution for a cryptocurrency mining operator. The contracted project will serve to provide specifications, optimization, as well as permit ready design for a modular DC-Centric microgrid. The CleanSpark design will be optimized to feed DC and AC loads and ensure maximum efficiency from solar generation technology paired with energy storage.

The containerized solution, along with the mPulse controller will permit a broad array of applications, from Bitcoin and Cryptocurrency mining, to a completely 'off-grid' agricultural grow facility power source, to a power demand management solution as the end use-case drivers suggest. 

CleanSpark, Inc. (CLSK), closed Thursday's trading session at $1.88, up 4.44%, on 19,194 volume with 27 trades. The average volume for the last 3 months is 34,528 and the stock's 52-week low/high is $0.899/$15.01.

chart

First Acceptance Corporation (FACO)

Zacks, Amigo Bulls, MarketWatch, YCharts, Barchart, InvestorsHub, Stockhouse, OTC Markets, Stockwatch, Stockopedia, Penny Stock Hub, TradingView, Simply Wall St, 4-Traders, The Street, and Capital Cube reported earlier on First Acceptance Corporation (FACO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

First Acceptance Corporation is primarily a retailer, servicer and underwriter of non-standard personal automobile insurance. At present, the Company conducts its insurance servicing and underwriting operations in 13 States. It operates only as an insurance agency in three States. Moreover, First Acceptance is licensed as an insurance company in 13 States where it does not conduct any business. OTCQX-listed, First Acceptance has its corporate office in Nashville, Tennessee.

First Acceptance issues non-standard automobile insurance policies to individuals based on their inability or unwillingness to obtain insurance coverage from standard carriers due to a variety of factors. These include their payment history or need for monthly payment plans, failure to maintain continuous insurance coverage, or driving record.

First Acceptance’s insurance operations generate revenue from selling non-standard personal automobile insurance products and related products in 16 States. The Company mainly distributes its products by way of its retail locations, and also through a call center and the Internet.

At March 31, 2018, First Acceptance leased and operated 349 retail locations and a call center staffed by employee-agents. The Company’s products include Auto Insurance, Renters Insurance, Motorcycle Insurance, Roadside Assistance, Hospital Benefits, Ohio Bond Policy, as well as Med Pay.

Earlier this month, First Acceptance reported its financial results for the three and nine months ended September 30, 2018. Income before Income Taxes, for the three months ended September 30, 2018 was $6.5 million, versus $3.4 million for the three months ended September 30,2017. Net Income for the three months ended September 30, 2018 was $5.2 million, versus $2.0 million for the three months ended September 30,2017. Basic and diluted Net Income per Share were $0.12 for the three months ended September 30, 2018, versus $0.05 for the same period in the year prior.

Mr. Ken Russell, President and Chief Executive Officer, said, "I am pleased to report that our Company continues to achieve consistent profitability by maintaining more disciplined underwriting and appropriate pricing of premiums. We have now recovered sufficient statutory capital to bring our underwriting leverage below the 3-to-1 regulatory guideline. Additionally, our continued risk management, as well as strong consistent claims handling, have resulted in a solid 74.8 percent loss ratio for the current accident year."

First Acceptance Corporation (FACO), closed Thursday's trading session at $1.14, down 0.87%, on 85,200 volume with 69 trades. The average volume for the last 3 months is 25,807 and the stock's 52-week low/high is $0.75/$1.499.

chart

International Stem Cell Corp. (ISCO)

Tiny Gems, Tip.us, MissionIR, StocksToBuyNow, Marketbeat.com, and Serious Traders reported earlier on International Stem Cell Corp. (ISCO), and we also report on the Company, here at the QualityStocks Daily Newsletter.

International Stem Cell Corp. is a clinical stage biotechnology company. It is developing stem cell-based therapies and biomedical products. The Company’s emphasis is on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. International Stem Cell’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs).

International Stem Cell is headquartered in Carlsbad, California. The Company has a research facility in Oceanside, California. International Stem Cell lists on the OTC Markets Group’s OTCQB.

The hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. They offer the potential to create the first true stem cell bank, UniStemCell™. The UniStemCell™ bank is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use. The human leukocyte antigen (HLA) system represents antigens essential for transplantation.

Company scientists have created the first parthenogenetic, homozygous stem cell line. This line can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages, and racial backgrounds with minimal immune rejection post transplantation.

International Stem Cell produces and markets specialized cells and growth media for therapeutic research internationally through its subsidiary Lifeline Cell Technology (Frederick, Maryland) and stem cell-based skin care products via its subsidiary Lifeline Skin Care.

This week, International Stem Cell announced that the United States Patent and Trademark Office (USPTO) granted the Company a key patent (US9926529B2) on the method used to manufacture ISC-hpNSC. These are the cells administered in the Company’s continuing Parkinson’s disease clinical trial.  They can potentially be used in therapies to treat traumatic brain injury and stroke.

The patent covers the procedure where human pluripotent stem cells (hpSCs) that have the potential to differentiate into essentially all cell types in the human body, are chemically differentiated into neural stem cells (NSCs). NSCs are self-renewing cells that generate the neurons and glia of the central nervous system (CNS). Generating NSCs from hpSCs has proved to be a scalable method. This method is easily adapted for manufacturing under GMP (Good Manufacturing Practices).

International Stem Cell Corp. (ISCO), closed Thursday's trading session at $1.63, up 0.62%, on 655 volume with 6 trades. The average volume for the last 3 months is 4,159 and the stock's 52-week low/high is $1.25/$1.77.

chart

Lixte Biotechnology Holdings, Inc. (LIXT)

Real Pennies, Stockhouse, 4-Traders, MarketWatch, InvestorsHub, and Simply Wall St reported on Lixte Biotechnology Holdings, Inc. (LIXT), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. is a drug discovery company listed on the OTC Markets Group’s OTCQB. It uses biomarker technology to identify enzyme targets associated with serious common diseases and subsequently designs novel compounds to attack those targets.

Lixte’s product pipeline covers two major categories of compounds at different stages of pre-clinical and clinical development that it believes have wide-ranging therapeutic potential for cancer and other debilitating and life-threatening diseases. A clinical-stage company, Lixte Biotechnology has its corporate office in East Setauket, New York.

Lixte’s cancer drug development strategy has led to the discovery of novel compounds. The phosphatase inhibitors are in pre-clinical development for reducing the extent of tissue damage following stroke, heart attack, and septic shock. The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis.

The Company’s dedication is to discovering drugs for more effective treatments for cancer. It has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models.

Lixte Biotechnology’s current drug portfolio includes inhibitors of serine/threonine protein phosphatases, which are vital to cell division. Its portfolio also includes DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

Lixte Biotechnology’s innovative phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations.

The Company granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). LB-100 is not presently approved for treatment of HCC.

Lixte Biotechnology’s strategy is to attack novel enzyme targets. This strategy has led to the discovery that its phosphatase inhibitors may be therapeutically useful not only in cancer but for treatment of important non-neoplastic diseases. This includes stroke and heart attack, vascular complications of type 2 diabetes, as well as severe depression.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Thursday's trading session at $1.00, up 11.11%, on 560 volume with 5 trades. The average volume for the last 3 months is 14,301 and the stock's 52-week low/high is $0.1205/$1.84.

chart

OptimizeRx Corp. (OPRX)

Streetwise Reports, Marketbeat.com, and Bull in Advantage reported on OptimizeRx Corp. (OPRX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OptimizeRx Corp. provides inventive consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. The Company does so while providing pharmaceutical and healthcare companies effective ways to expand awareness, access, and adherence to their medications. OptimizeRx is the foremost aggregator of pharmaceutical-sponsored services in electronic health record (EHR) platforms. The Company’s core product is SampleMD. A health technology software company, OptimizeRx has its headquarters in Rochester, Michigan.

The Company first launched its SampleMD e-coupon solution in April 2015 within Practice Fusion's EMR. It promotes patients’ savings and support from the world's largest pharmaceutical companies. These include Pfizer, Lilly, Novartis, AstraZeneca, and many others.

OptimizeRx’s SampleMD replaces drug samples with electronic trial vouchers and co-pay coupon savings. These are electronically added to an e-Prescription and sent electronically to the pharmacy and are integrated within top Electronic Health Record (EHR) platforms in the nation. These include Allscripts, DrFirst, NewCrop, Quest Diagnostics, and Practice Fusion, and other EHRs.

In addition, OptimizeRx launched its OPTIMZEHR™. This is its consulting and implementation practice to assist pharmaceutical-biotechnology companies and healthcare provider platforms in determining and executing on mutually beneficial opportunities to jointly assist physicians and patients within their EHR workflow.

OptimizeRx has a group of services that integrate complete brand support into the EHR. This leads to enhanced patient care and improved outcomes. The offerings include Brand Messaging and Brand Support. OptimizeRx’s core product has been financial messaging, providing physicians with electronic coupons, co-pay offers, and vouchers for their patients at the point of care (PoC).

Last month, OptimizeRx reported results for Q3 ended September 30, 2017. Net revenue rose 74 percent to a record $3.1 million. This was driven by growth in financial and brand messaging by new and returning clients. Financial messages, such as eCoupons, and brand messaging were distributed for over 100 pharmaceutical brands during Q3.

Net loss for Q3 of 2017 was $623,000 or $(0.02) per share, versus a net loss of $243,000 or $(0.01) per share in Q3 of 2016.

OptimizeRx has directly integrated its financing messaging with Amazing Charts, a foremost EHR and subsidiary of Harris Healthcare, to help patients save money and be better educated about prescriptions. OptimizeRx services will operate seamlessly within the Amazing Charts EHR workflow and alert health care providers (HCPs) to prescription savings and support information for patients. The integration is now in beta. It is planned for general release by the end of this month.

Amazing Charts provides EHR, practice management, and other Health IT solutions. These have been adopted by over 11,000 clinicians in more than 7,500 private practices.

OptimizeRx Corp. (OPRX), closed Thursday's trading session at $16.24, up 8.27%, on 12,954 volume with 147 trades. The average volume for the last 3 months is 59,986 and the stock's 52-week low/high is $7.00/$18.39.

chart

PEN, Inc. (PENC)

DreamTeamNetwork, Outcast Traders, and SmallCapVoice reported earlier on PEN, Inc. (PENC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, PEN, Inc. is an international leader in developing, commercializing, and marketing enhanced-performance products enabled by nanotechnology. PEN stands for Products Enabled by Nanotechnology. Products from its family of companies are for healthcare to homecare, homeland defense to food security, and transportation to recreation. PEN has its head office in Miami, Florida.

PEN is the combination of Nanofilm, Ltd. and Applied Nanotech Holdings, Inc. These are two nanotechnology innovators. PEN formed to channel the potential of nanotechnology in real-world products for real-world users. With the combination of these two companies, PEN provides nano-layer coatings, nano-based cleaners, as well as nano-composite products.

PEN’s Applied Nanotech, Inc. subsidiary is based in Austin, Texas. It functions as the Design Center conducting contract services for government and private customers and new product development for PEN centering on inventive and advanced product solutions in the areas of safety, health, and sustainability.

Applied Nanotech Holdings (the PEN Design Center) has over 25 years in the industry. It holds in excess of 250 patents. It has partnered with organizations like the U.S. Department of Transportation, the Army Research Office, and the U.S. Department of Agriculture to find nanotechnology-based solutions to challenges.

PEN, via its wholly-owned subsidiary PEN Brands LLC (formerly Nanofilm Ltd.), develops, manufactures, and sells products based on nanotechnology. This includes its Ultra Clarity® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products, CLARITY ULTRASEAL® nanocoating products for glass and ceramics, and an environmentally friendly surface protector, fortifier, and cleaner.

Last month, PEN reported financial results for its Q3 ended September 30, 2017. For the quarter, total revenues were $2,028,261, versus revenues of $2,006,838 in the comparable period in 2016.

For Q3 of 2017, overall gross profit amounted to $632,982 versus $631,083 for the Q3 of 2016. Gross margin was 31 percent. This was relatively unchanged from the prior year period.

Operating loss was $48,131 in Q3 of 2017, versus an operating loss of $235,772 in Q3 of 2016. Net loss for the three months ended September 30, 2017 was $124,730 or ($0.04) per basic and diluted share, versus a net loss of $210,902, or ($0.07) per basic and diluted share, for the three months ended September 30, 2016.

PEN, Inc. (PENC), closed Thursday's trading session at $0.44, up 7.32%, on 509 volume with 3 trades. The average volume for the last 3 months is 951 and the stock's 52-week low/high is $0.353/$1.58.

chart

Newgioco Group, Inc. (NWGI)

OTC Markets, TradingView, MarketWatch, and LAST10K.com reported on Newgioco Group, Inc. (NWGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Newgioco Group, Inc. is a betting software technology company. It provides regulated leisure lottery and gaming products and services via licensed subsidiaries based in Europe. The Company, together with its wholly-owned subsidiaries, is a fully-licensed and integrated gaming software technology enterprise.

Newgioco Group has its corporate office in Toronto, Ontario, as well as an office in Rome, Italy. The Company’s shares trade on the OTC Markets’ OTCQB. Newgioco has acquired Multigioco Srl, which is a licensed gaming operator headquartered in Rome.

Newgioco Group plans to aggressively go after attractively priced, fragmented, and profitable gaming operators in Italy. Its aim is to become a top tier gaming operator over a five-year investment time horizon.

Newgioco Group provides its clients a complete set of leisure gaming products and services. These include sports betting, virtual sports, online casino, poker, bingo, lottery, interactive games and slots, and a unique betting platform (www.odissea.at) providing Business-to-Business (B2B) and Business-to-Consumer (B2C) bet processing.

Newgioco Group conducts its business chiefly through retail neighborhood betting shops and an internet-based gambling and sports betting software platform under the registered brand Newgioco, by way of its licensed website www.newgioco.it located in Italy.

In July, Newgioco Group announced that it obtained certification on its betting software platform required by the Italian gaming authority, the Agency of Customs and Monopolies (ADM). By attaining this globally recognized ADM Certification, Newgioco stated that it has demonstrated its dedication to the highest level of security standards and continuous improvement in betting software development, implementation, and oversight.

In early August, Newgioco Group announced the successful launch of its new Betting Platform Technology colloquially called "ELYS." The ELYS software platform went live on August 1, 2017. Therefore, sports betting operations are now processed in-house via ELYS, while skill games, lottery, casino, poker, and other entertainment products will continue through the Company’s strong relationship with Microgame SpA.

In addition, this month, Newgioco Group announced that it filed its 2017 Q2 results with the U.S. Securities and Exchange Commission (SEC). It reported Income Before Interest and Income Tax of $326,616. This represents a profit of $0.01 per share for Q2 of 2017. Non-GAAP Gaming Turnover saw a noticeable improvement, surpassing $102 million for the six months ended June 30, 2017, versus $54.9 million in the prior year.

GAAP Revenue was $7.97 million for the six months ended June 30, 2017, versus $3.27 million for the same period in 2016. This represents an increase of 143.5 percent. The Company’s Total Assets more than doubled from about $3.4 million to $7.25 million, and Cash reserves increased from $121,130 to $2.125 million.

Newgioco Group, Inc. (NWGI), closed Thursday's trading session at $0.50, up 25.00%, on 21,681 volume with 11 trades. The average volume for the last 3 months is 33,304 and the stock's 52-week low/high is $0.145/$1.78.

chart

Kutcho Copper Corp. (KCCFF)

InvestorX, Wallet Investor, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Junior Stock Review, Investors Hangout, The Prospector News, Mining & Energy, Stock Orange, Resource World, Dividend Investor, Stockhouse, Stockwatch, MarketWatch, and Barchart reported earlier on Kutcho Copper Corp. (KCCFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A resource development company, Kutcho Copper Corp. focuses on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. The Company’s intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. Kutcho Copper is based in Vancouver, British Columbia (B.C.).

The Kutcho Copper Project is the Company’s 100 percent owned high grade copper-zinc development project in northern B.C. This Project is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho has a Probable Reserve of 10.4 Mt grading 2.01% Cu and
3.19% Zn (2.92% CuEq).

The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves
and considerably increase production capacity. The Wheaton Precious Metals stream establishes a foundation for a strong partnership and reduces financial risk of the Project. In addition, there is the potential for more discoveries through exploration. Kutcho Copper’s aim is to boost reserves from the current 10.4 Mt via existing resource conversion.

Kutcho Copper has launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world’s largest streaming companies, an international base and precious metals and concentrates trading company and a global financial institution providing banking services in the metals and mining industry. MineHub is a cutting-edge technology company leveraging blockchain technology to develop a new generation of applications for the metals and mining industry.

Last week, Kutcho Copper announced drill results from the Main deposit at its Kutcho high grade copper-zinc project. Highlight intersections from the Main deposit include KC18-261 with 9.9m of 1.29% Cu, 4.1% Zn, 35.1 g/t Ag, 0.34 g/t Au or 3.5% CuEq (including 4.4m of 5.0% CuEq).

Highlight intersections also include KC18-271 with 9.9m of 2.79% Cu, 0.9%Zn, 72.9 g/t Ag, 0.45g/t Au or 4.1% CuEq (including 2.8m of 10.9% CuEq). Additionally, highlight intersections include KC18-285 with 4.9m of 0.87% Cu, 4.3% Zn, 20.6g/t Ag, 0.18g/t Au or 2.89% CuEq (including 2.3m of 5.0% CuEq).

Kutcho Copper Corp. (KCCFF), closed Thursday's trading session at $0.1939, even for the day. The average volume for the last 3 months is 9,109 and the stock's 52-week low/high is $0.194/$0.835.

chart

The QualityStocks Company Corner

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions, Inc. (SGSI), a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets, today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW"). Also today, NetworkNewsWire released a report on the company detailing how SGSI is “One to Watch.”

is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.2385, off by 14.82%, on 46,914 volume with 23 trades. The average volume for the last 3 months is 739,662 and the stock's 52-week low/high is $0.221/$2.59.

Recent News

chart

Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce the appointment of Constantine Constandis to the Advisory Board. Mr. Constandis is a global C-level executive with over 34 years of experience in the wine and spirits industry in Canada, USA, Europe and Asia. Also today, Investorideas.com released a report on the company detailing how companies like Sproutly, who have secured a proprietary water soluble technology which is being readied for the market, have now pushed their focus towards people. As cannabis focused companies prepare to enter into the infused beverage market, finding seasoned experience to enter into the international and national beverage markets has become paramount, as many of the technologies and R & D reach their final stages and are now simply waiting on legislation. Additionally, NetworkNewsWire released a report on the company detailing how SGSI is “One to Watch.”

Sproutly Canada, Inc. (OTC: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTC: SRUTF), closed the day's trading session at $0.281, up 13.31%, on 226,391 volume with 131 trades. The average volume for the last 3 months is 142,025 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP), a client of CNW focused on licensing disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.13, up 6.60%, on 114,396 volume with 145 trades. The average volume for the last 3 months is 237,510 and the stock's 52-week low/high is $0.741/$2.54.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) announced a partnership with Feldmann Nagel Cantafio Margulis, PLLC, a boutique lawfirm formed in early 2004 by Charles Feldmann and David Nagel, with deep cannabis compliance expertise throughout the United States, Israel, and the international cannabis marketplace. As an extension of the Cannabis Strategic Ventures Team, Charles E. Feldmann, Founding Partner, will lead the legal team on matters related to cannabis enforcement, licensing, federal risk mitigation and compliance related issues at the local, state, national and international level.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.90, off by 1.55%, on 55,691 volume with 78 trades. The average volume for the last 3 months is 59,587 and the stock's 52-week low/high is $0.032/$7.13.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CHMJF).

Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to announce that the application requesting receipt of a Continuous Use Permit for a Cannabis Cultivation, Processing and Distribution Facility has been submitted to the City of Desert Hot Springs, California. Also today, CannabisNewsAudio announces the Audio Press Release (APR) titled “Why Companies Are Buying Up Assets in the American Cannabis Market,” featuring Chemistree Technology. To hear the CannabisNewsAudio version, visit: http://cnw.fm/7eP0F. To read the full editorial, visit: http://cnw.fm/U0pIy.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements’ expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company “maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S.”

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree’s working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.349, up 4.49%, on 140,525 volume with 99 trades. The average volume for the last 3 months is 3,417 and the stock's 52-week low/high is $0.268/$0.7158.

Recent News

chart

CytoDyn Inc. (CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn Inc. (OTC.QB: CYDY) announces that results from a recent clinical study showed that CytoDyn’s PCaTest provides substantial additive discriminative value for predicting outcomes of patients diagnosed with prostate cancer compared to the Gleason score, the current standard for prostate cancer diagnosis. The positive clinical data from two groups totaling 218 patients and followed for 10 years adds to three prior clinical studies conducted in more than 350 patients that demonstrated a high predictive value for CytoDyn’s PCaTest in determining outcome of men diagnosed with prostate cancer. The new findings support the Company’s strategy for seeking U.S. Food and Drug Administration (FDA) approval for the PCaTest. Also today, the company was highlighted in Venture Breakfast Bits, by 24/7 Market News.

CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.59, off by 0.84%, on 310,007 volume with 78 trades. The average volume for the last 3 months is 224,543 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

As the cannabis market continues to evolve and experiencing a compounding rate of growth due to factors such as legalization, product advancements and rising consumer interest, cannabis companies are heavily investing in the expansion of operations. The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada. Also today, the company was highlighted in an article from Regal Consulting.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.45, off by 1.21%, on 367,359 volume with 606 trades. The average volume for the last 3 months is 1,538,893 and the stock's 52-week low/high is $1.87/$7.894.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that its President and Chief Financial Officer, Dave Briskie, will present at the 11th annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Also today, the company was highlighted in an article from Financialnewsmedia.com.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.82, off by 4.21%, on 151,042 volume with 687 trades. The average volume for the last 3 months is 550,435 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTCQB: SHRV) today announces that its wholly owned Elevacity Global subsidiary will launch its line of nutraceutical products in the provinces of Ontario and British Columbia, Canada, in December 2018. The Company is currently awaiting approvals for enrollment opportunities in all other Canadian provinces, responding to international demand for its products.

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.30, off by 1.64%, on 15,569 volume with 7 trades. The average volume for the last 3 months is 12,223 and the stock's 52-week low/high is $0.125/$0.589.

Recent News

chart

GreenBox POS, LLC (GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (GRBX) is pleased to announce it has entered into a joint venture agreement with Sigue Corporation ("Sigue"), one of the world's largest private money transfer entities. Operating in over 100 countries and employing nearly 200,000 agents, Sigue will offer GreenBox the capacity and infrastructure to deploy the Company's blockchain transactional technology on an exponentially broader scale.

GreenBox POS, LLC (GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.41, up 14.53%, on 86,868 volume with 13 trades. The average volume for the last 3 months is 18,557 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Departure of US AG and Democratic House Control Improve Prospects for Hemp Industry,” featuring Marijuana Company of America, Inc. (OTC: MCOA). To hear the CannabisNewsAudio version, visit: http://cnw.fm/5oxVz. To read the full editorial, visit: http://cnw.fm/NpUA5.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0176, off by 1.68%, on 8,804,831 volume with 267 trades. The average volume for the last 3 months is 8,720,863 and the stock's 52-week low/high is $0.0166/$0.0728.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Cannabis Boom Fuels Mergers and Acquisitions in Hydroponics and Beyond,” featuring Sugarmade, Inc. (OTCQB: SGMD). To hear the CannabisNewsAudio version, visit: http://cnw.fm/aeM3R. To read the full editorial, visit: http://cnw.fm/5Kj62. Also today, NetworkNewsWire released a report on the company detailing how SGMD has the opportunity to execute its ambitious plans to support cannabis cultivation, now that further changes in the legal framework are allowing the industry to emerge from its long winter.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0861, off by 11.24%, on 4,584,805 volume with 316 trades. The average volume for the last 3 months is 2,209,718 and the stock's 52-week low/high is $0.07/$0.43.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTCQB: SING), a client of CNW focused on acquiring companies that will benefit from the injection of growth capital and technology integration. To view the full publication, titled “Political Change and E-commerce Drive Ongoing Growth for Cannabis Industry,” visit: http://cnw.fm/Kdxq9. Also today, NetworkNewsWire released a report on the company detailing how SING is celebrating the rollout of new products to the cannabis-infused wellness market by subsidiary SingleSeed at the same time that its already-launched Lalpina CBD Water is reporting a successful first week of sales.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0196, off by 1.90%, on 4,290,734 volume with 158 trades. The average volume for the last 3 months is 4,414,800 and the stock's 52-week low/high is $0.0178/$0.133.

Recent News

chart

American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water Corp. (HIPH) was highlighted in an article examining how the 2018 Farm Bill is "very close to passing" according to Collin Peterson, Rep D-Minnesota, and added with the recent legalization in Canada, there has been a focus on companies in the recreational and medical cannabis sector. But there has been a shift in the attitude with people's perception of marijuana, as it's viewed more than a recreational drug but as a wellness product.

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: SingleSeed.com and DIGSHydro.com. SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.031, off by 8.82%, on 30,593,637 volume with 847 trades. The average volume for the last 3 months is 18,117,063 and the stock's 52-week low/high is $0.0035/$0.1319.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.